Eureka Moments
Dr. Sahar Ghorbanpour
“We are successfully recreating in vitro placenta models using organoids.”
Sahar Ghorbanpour, PhD
Head of the TEBB Lab,
Technische Universität Graz.
How human-relevant tissue models are opening new possibilities for understanding pregnancy disorders
How can advanced human-relevant tissue models help researchers better understand pregnancy disorders that have long remained difficult to study? In this conversation with Dr. Sahar Ghorbanpour, Head of the Tissue Engineering, Biomaterials, and Bioelectricity Lab at Graz University of Technology, we discuss how these models are becoming increasingly important tools for researchers investigating pregnancy disorders.
Technische Universität
Graz, Austria
It’s a well-known fact that pregnancy disorders are a research field that’s been difficult to study. Not because researchers didn’t care, but because pregnancy biology is complex. Ethical considerations, fetal development and dynamic changes throughout pregnancy, incomplete methods, and a historical focus on male physiology in biomedical research have all contributed to the challenge. The hurdles are many, as are the explanations for why research on pregnancy disorders has lagged. But with the emergence of human-relevant models, a new way of approaching pregnancy disorders has opened.
At the Institute of Healthcare Engineering at Graz University of Technology, Dr. Sahar Ghorbanpour leads a multidisciplinary research group working at the intersection of biology, biomaterials, biomechanics, and bioengineering. Her laboratory focuses on developing physiologically relevant 3D human tissue models that recreate one of the most complex and least understood processes in human biology: pregnancy and the maternal–fetal interface.
“We are trying to develop systems that can be used to study human disease, but more specifically, women’s reproductive organs. We are not only interested in pregnancy itself. We study complications that happen before, during, and after pregnancy,” Dr. Ghorbanpour says.
For Dr. Ghorbanpour, the motivation behind the work extends far beyond women’s health alone.
“Every human life begins in the womb. What happens during those nine months affects health throughout the entire lifespan. Not only for the mother, but also for the child,” Dr. Ghorbanpour says and continues:
“This process is extremely complex and largely inaccessible for us to study, especially during the first trimester. I often describe it as the hidden phase of pregnancy. What we are trying to do is shed more light on this hidden phase.”
Unlike many other tissues, the maternal–fetal interface cannot easily be sampled or experimentally accessed during early pregnancy due to both ethical and clinical limitations, resulting in limited access to physiologically relevant human samples.
“You cannot simply take tissue samples from pregnant women during early pregnancy. It would be unethical and could put both mother and baby at risk.”
Traditional research models have also struggled to bridge this gap. While animal models have long been used in reproductive research, Dr. Ghorbanpour emphasizes that many pregnancy disorders are uniquely human.
“A lot of pregnancy complications are unique to humans or are not faithfully reproduced in commonly used animal models. If the physiology is fundamentally different, we cannot expect those systems to fully explain human pregnancy complications,” Dr. Ghorbanpour says.
To address this challenge, Dr. Ghorbanpour and her team rely on cell and tissue samples from patients. Something Dr. Ghorbanpour is very appreciative of.
“Many of the cells and tissue samples we use in our research come directly from patients, including samples from miscarriages, preeclampsia, and stillbirth cases. The willingness of patients and families to donate samples during such fragile and emotionally difficult situations means a great deal to us and to the research community. It is never an easy decision during such a challenging journey, and we are always deeply aware of the trust and responsibility associated with these samples,” she says.
Scientists from different research groups across the Institute of Health Care Engineering
Image source: Oliver Wolf – TU Graz
Human-relevant models are changing the field
Over the last decade, the emergence of organoids, microphysiological systems, and advanced 3D culture technologies has begun to transform how researchers approach pregnancy biology. According to Dr. Ghorbanpour, these systems are already providing insight that was previously inaccessible.
“I believe these 3D systems are helping us not only understand the origins and progression of disease,but also identify biomarkers for diagnosis and develop new therapeutic strategies.”
During her earlier research, Dr. Ghorbanpour developed a vascularized microfluidic placenta-on-a-chip model for investigating biomarkers associated with preeclampsia, a severe pregnancy complication affecting both mother and baby. Using this model, the research team identified biomarkers that contributed to the subsequent development of a rapid point-of-care diagnostic platform capable of detecting the condition in less than 15 minutes.
“This was one of the biggest limitations clinicians faced. Pregnancy complications can progress very quickly, and early detection is critical.”
This underlines the broader implication that physiologically relevant human models
Recreating the maternal-fetal interface in vitro
One of the central goals of Dr. Ghorbanpour’s laboratory is to recreate the maternal–fetal interface, also recognized as one of the body’s most complex and dynamic biological environments.
The challenge extends far beyond growing cells in three dimensions.
“We are not only dealing with cellular complexity, but also with two different biological systems simultaneously. The maternal side and the fetal side. The environment changes dramatically between the first, second, and third trimesters. Oxygen levels change, mechanical forces change, and the biology evolves continuously over time,” Dr. Ghorbanpour says.
To address this, her group cultures tissue systems dynamically across pregnancy-like timelines rather than studying isolated snapshots. Specifically, Dr. Ghorbanpour’s group recreates the biological environment through a combination of maternal and fetal cell populations, tissue-specific biomaterials, controlled oxygen conditions, and dynamic environmental cues that change throughout pregnancy.
“We do not want to only observe a single moment of disease. We want to understand where disease begins and how it progresses over time.”
A major part of this work relies on dynamic bioreactor systems capable of supporting long-term tissue maturation under physiologically relevant conditions. Using Celvivo’s ClinoStar platform, Dr. Ghorbanpour’s laboratory gradually modifies environmental conditions over extended culture periods to mimic changes occurring throughout pregnancy.
“We start with conditions that resemble the first trimester, and then we continuously adapt the environment as the tissue develops. We add the dimension of time,” Dr. Ghorbanpour says and continues:
“The tissues are not static. They continuously reorganize and evolve as pregnancy progresses. As a result, we started seeing structures organizing themselves in ways that resemble the human placenta. They formed vessels, lumens, and maternal–fetal interfaces.”
Importantly, the tissues also began orienting themselves in ways that closely mirror native placental organization, which is something many static models struggle to achieve.
“These cells are extremely intelligent. When they sense the right environment, they remember where they came from.”
3D rendering of a human 3D placental tissue model acquired by light-sheet fluorescence microscopy, illustrating the complex three-dimensional spatial organization of trophoblast populations. Syncytiotrophoblasts are shown in yellow, extravillous trophoblasts in orange, and cytotrophoblasts in magenta.
Confocal fluorescence image of a 3D human placental organoid demonstrating the complex spatial organization of the three major trophoblast populations. Cytotrophoblasts are shown in magenta, syncytiotrophoblasts in cyan, and extravillous trophoblasts in yellow.
Confocal fluorescence image of a vascularized 3D human placental tissue model demonstrating the formation of a branching vascular network. Multiple vessel branches extend from the tissue, illustrating the integration of vascular and placental cell populations.
Vascularized 3D human placental model of late-onset preeclampsia generated from primary human placental cells. Cyan indicates trophoblast cells, while red marks endothelial cells forming the vascular network.
Apply predictive 3D modelling to your work
Contact us to refine your research today. Let us know if you have questions about Celvivo, our technology, or implementing NAMs.
Why dynamic environments matter
For Dr. Ghorbanpour, one of the major limitations of many traditional culture systems is that they fail to replicate the physical environmental experience inside the human body. Mechanical stimulation, oxygen concentration, and nutrient transport all influence how tissues develop and function.
“If we expose cells to environments that are not physiologically relevant, the cells behave differently. That changes the reliability of the results.”
This is particularly important in larger tissue constructs, where static systems often develop necrotic cores as nutrients and oxygen fail to penetrate the center of the tissue. Using dynamic systems, Dr. Ghorbanpour’s group has been able to maintain larger and healthier tissue structures over extended periods. Furthermore, the group has also been able to control oxygen levels, which have proven critical in modeling healthy and diseased pregnancy states.
“In early pregnancy, oxygen levels are naturally low. Later, they increase. In pregnancy complications, those patterns change again. The dynamic system allows us to reproduce both healthy and dysfunctional conditions,” Dr. Ghorbanpour says, and continues.
“One of the major advantages is improved oxygen and nutrient transfer throughout the tissue. Even after long culture periods, the tissues remain healthy and viable.”
Looking beyond single organs
While much of the work in Dr. Ghorbanpour’s group focuses on placental biology, the group increasingly studies how multiple organ systems communicate during pregnancy.
The laboratory combines placental tissues with cardiovascular models, including miniature beating heart systems, to investigate how dysfunction in one tissue affects another.
“We are interested in communication between tissues. Looking at only one organ does not give us the full picture,” Dr. Ghorbanpour says.
In one study, her team observed that placental dysfunction altered the behavior of cardiac tissues cultured within connected microphysiological systems.
“When dysfunctional placental models were connected to cardiac tissues, we observed changes in the beating behavior of the heart tissue.”
These findings reinforce an increasingly central concept in human-relevant biology, showing that diseases rarely exist in isolation.
Dr. Sahar Ghorbanpour and her multidisciplinary research team at Graz University of Technology developing advanced 3D human tissue models for women’s reproductive health and disease.
Dr. Sahar Ghorbanpour holding a Celvivo bioreactor containing a 3D human uterine organoid, an advanced tissue model designed to study women’s reproductive health and disease.
Image source: Oliver Wolf – TU Graz
Dr. Sahar Ghorbanpour
Dr. Sahar Ghorbanpour began her academic career as a research scientist at the University of Natural Resources and Life Sciences, Vienna (BOKU), Austria. She then completed her PhD at the University of Technology Sydney, where she continued her postdoctoral research until 2024. Today, she is Head of the Tissue Engineering, Biomaterials and Bioelectricity Lab at Graz University of Technology (TU Graz), Austria.
Dr. Sahar Ghorbanpour
Dr. Sahar Ghorbanpour began her academic career as a research scientist at the University of Natural Resources and Life Sciences, Vienna (BOKU), Austria. She then completed her PhD at the University of Technology Sydney, where she continued her postdoctoral research until 2024. Today, she is Head of the Tissue Engineering, Biomaterials and Bioelectricity Lab at Graz University of Technology (TU Graz), Austria.
Toward a more human-centered future for women’s health research
Looking ahead, Dr. Ghorbanpour hopes the field moves toward increasingly integrated and physiologically relevant systems capable of modeling human biology more accurately across diverse populations.
“It is very important for me that these technologies become inclusive. Pregnancy complications affect women differently across populations and ethnicities, and our models need to reflect that diversity.”
She also hopes these systems will enable earlier diagnosis, more personalized therapies, and safer drug testing during pregnancy, areas that remain severely limited today.
“There are many drugs we cannot properly test during pregnancy because of the risks involved. If we have reliable human-relevant systems, we can study toxicity, efficacy, and long-term effects much more safely.”
For Dr. Ghorbanpour, the future of the field depends on scientific progress, as well as greater awareness and investment in women’s health research.
“We need more funding, more awareness, and more focus on these diseases. These complications affect millions of women worldwide, yet many remain underdiagnosed and poorly understood.”
Despite the challenges ahead, she remains optimistic about what human-relevant models may enable over the coming decade.
“We are getting closer. For the first time, we are beginning to build systems that can truly help us understand how these complications start.”
Learn more about the work from Dr. Sahar Ghorbanpour and her group at the TEBB Lab here.



